Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel B Keller

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
AIDS (London, England)|November 10, 2011
The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxisSamuel B Keller, Davey M Smith
AIDS and Behavior|July 15, 2014
Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study)Helen L King, Samuel B Keller, Michael A Giancola, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
AIDS (London, England)|November 10, 2011
The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxisSamuel B Keller, Davey M Smith
AIDS and Behavior|July 15, 2014
Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study)Helen L King, Samuel B Keller, Michael A Giancola, et al.
Pageof 1